Company Long-Term Indebtedness: daxor.com (DXR)

Public company logo of daxor.com (DXR)

Daxor Corporation (DXR) growth relies on the implementation of BVA-100 systems within US cardiology, government defense contracts, and the sale of consumables. This price chart on the GURU.Markets platform, where the indicator stands at 0.00, confirms these trends. A team of leading technicians united by a common mission ensures this success. Meanwhile, current quotes already price in the gradual integration of the equipment into hospital resuscitation protocols.

daxor.com (DXR) Company Long-Term Debt: for the period 07/04/2022 - 10/30/2026

Daxor (DXR) - metric breakdowns and financial figures

- price and consensus price forecast:
Price Rate Chart Daxor Corp|DXR - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Daxor|DXR - Total Company Value
- balance sheet net asset value indicators:
Net Asset Value per Share Daxor|DXR - Company Book Value|Market Capitalization to Book Value daxor.com|DXR - Cumulative Company Assets
- debt level and financial liquidity data:
Aggregate Debt to Capital Daxor Corporation|DXR - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Daxor Corp|DXR - Company Aggregate Debts|Debt to Book Value Daxor|DXR - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Daxor|Quick Liquidity Indicator daxor.com
- earnings and market multiples details:
DXR - Net Profit
Summary company analytics:DXR - Daxor Corporation
Product sample of Daxor Corporation

This indicator captures total liabilities with a maturity of more than one year, where rising values signal a risk of cash flow gaps when servicing loans. By analyzing the long-term debt of the corporation, an investor assesses the financial stability of Daxor Corporation (DXR), which is critical given the company's dependence on regulatory approvals for devices and potential disruptions in the supply of electronic components.

Competitor analysis for Daxor Corporation

Long-Term Indebtedness abbott.com|TMO - Company Long-Term Debt|GEHC (GE HealthCare Technologies Inc.) - Company Long-Term Indebtedness|Mettler-Toledo International Inc. (MTD) - Company Long-Term Debt|Long-Term Debt Waters Technologies (WAT)|Company Long-Term Debt Bio-Techne Corporation|bruker.com (BRKR) - Long-Term Debt Volume|Company Long-Term Liabilities AZTA (Azenta)|Amount of Long-Term Liabilities VREX|Company Long-Term Debts SMLR (Semler Scientific Corp)|Long-Term Debt Volume Butterfly Corp (BFLY)|Mesa Laboratories, Inc. - Company Long-Term Debts|quantum-si.com (QSI) - Company Long-Term Liabilities|NNOX (Nano-X) - Company Long-Term Liabilities|Quanterix Corp. - Company Long-Term Loans and Borrowings|Company Long-Term Debt 908 Devices Corp|Company Long-Term Liabilities CapsoVision Medical (CV)|Company Long-Term Debts MXCT|RPID - Long-Term Debt|Company Long-Term Debts SEER (Seer)|HYPR: Company Long-Term Indebtedness|FONAR Corp - Company Long-Term Debts|Long-Term Debt Volume Spectral AI Inc. MDAI|VIVS: Company Long-Term Debts|Company Long-Term Liabilities aclarion.com|AKYA (Akoya Biosciences Inc) - Company Long-Term Debts|Company Long-Term Debts ThermoGenesis Holdings, Inc.|Company Long-Term Debt Talis Biomedical (TLIS)|Company Long-Term Debt TTOO (T2 Biosystems Inc)